Browsing: biotech
A mRNA-based cancer vaccine has shown impressive results in a small trial in patients with pancreatic cancer, showing that the…
In this week’s edition of The Prototype, we explore how Trump policies are impacting the research ecosystem, a new diamond…
Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
In this week’s edition of InnovationRx, we report from the scene of the year’s biggest healthcare conference, look at the…
In this week’s edition of The Prototype, we look at a new optical chip for data centers, turning fossil fuels…
Arnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
“Los Angeles, 2029 AD. The machines rose from the ashes of the nuclear fire. Their war to exterminate mankind had…
If you’re under 50 today, could you really live to 150? Geneticists and aging researchers weigh in
At the turn of the 20th Century, one could expect to live until 47 in the U.S. Now, medical advancements,…
Here’s how to delete your data from 23andMe if you’re worried about protecting your personal health information
Whether in search of relatives, a family’s country of origin, or to understand personal disease risk, 15 million people have…
The Trillion-Dollar Quest For Healthier Aging: How Hevolution Foundation Is Reshaping Longevity Research
In a world where global life expectancy is forecasted to increase from 73.6 years in 2022 to 78.1 years by…
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
Google cofounder Sergey Brin got a $366 million windfall from selling all his Tesla shares back in 2021—now he’s using…












